贝克尔肌营养不良症中基于定量肌肉MRI与功能评估选择最优生物标志物的方法
该研究在24个月内对贝克尔肌营养不良症(BMD)患者进行Dixon脂肪-水MRI和功能评估,采用基于标准化反应均值(SRM)的逐步方法筛选最佳生物标志物。结果显示所有肌肉中位脂肪分数(FF)增加,全大腿3中心层FF是最佳生物标志物(SRM 1.04,与动态测试相关性ρ≤-0.81,ICC 1.00,SD 0.23%,样本量59),相比NSAA可减少约40%样本量。
要点
- 全大腿3中心层FF是BMD疾病进展的最佳定量MRI生物标志物。
- 该标志物相比NSAA可减少约40%的临床试验样本量。
- 所有肌肉中位FF在24个月内增加,但收缩横截面积(cCSA)无一致变化。
核心结论
- 在BMD中,全大腿3中心层FF是最佳生物标志物,基于低SD和采集分析时间,且相比NSAA减少约40%样本量。
研究设计与样本
- 研究采用Dixon脂肪-水成像在基线(n=24)和24个月(n=20)对BMD患者进行纵向评估。
- 计算19块肌肉和6个肌肉组的3个中心层和全肌肉的脂肪分数(FF),以及中心层的收缩横截面积(cCSA)。
- 功能评估包括膝伸展和屈曲力以及3项动态测试(NSAA、10米跑、6分钟步行测试)。
- 使用SRM(≥0.8)和与所有动态测试的相关性(ρ≤-0.8)选择MRI指标,并基于ICC和差值SD评估。
- 样本量计算假设24个月内疾病进展减少50%,1:1随机化临床试验。
主要发现
- 所有肌肉中位全肌肉FF在24个月内增加0.2%至2.6%,无一致cCSA变化。
- 8个FF指标显示高SRM和强功能相关性,但无cCSA指标满足条件。
- 所有指标显示优秀ICC(≥0.999)和相似的评定者间差值SD。
- 全大腿3中心层FF的SRM为1.04,与动态测试相关性ρ≤-0.81,ICC为1.00,SD为0.23%,样本量为59。
关键数值与推荐
- MRI指标选择标准:SRM≥0.8且与所有动态测试相关性ρ≤-0.8。
- 全大腿3中心层FF:SRM 1.04,相关性ρ≤-0.81,ICC 1.00,SD 0.23%,样本量59。
临床怎么用
- 在BMD临床试验中,可采用全大腿3中心层FF作为疾病进展的定量生物标志物,以减小样本量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify the best quantitative fat-water MRI biomarker for disease progression of leg muscles in Becker muscular dystrophy (BMD) by applying a stepwise approach based on standardized response mean (SRM) over 24 months, correlations with baseline ambulatory tests, and reproducibility. METHODS: Dixon fat-water imaging was performed at baseline (n = 24) and 24 months (n = 20). Fat fractions (FF) were calculated for 3 center slices and the whole muscles for 19 muscles and 6 muscle groups. Contractile cross-sectional area (cCSA) was obtained from the center slice. Functional assessments included knee extension and flexion force and 3 ambulatory tests (North Star Ambulatory Assessment [NSAA], 10-meter run, 6-minute walking test). MRI measures were selected using SRM (≥0.8) and correlation with all ambulatory tests (ρ ≤ -0.8). Measures were evaluated based on intraclass correlation coefficient (ICC) and SD of the difference. Sample sizes were calculated assuming 50% reduction in disease progression over 24 months in a clinical trial with 1:1 randomization. RESULTS: Median whole muscle FF increased between 0.2% and 2.6% without consistent cCSA changes. High SRMs and strong functional correlations were found for 8 FF but no cCSA measures. All measures showed excellent ICC (≥0.999) and similar SD of the interrater difference. Whole thigh 3 center slices FF was the best biomarker (SRM 1.04, correlations ρ ≤ -0.81, ICC 1.00, SD 0.23%, sample size 59) based on low SD and acquisition and analysis time. CONCLUSION: In BMD, median FF of all muscles increased over 24 months. Whole thigh 3 center slices FF reduced the sample size by approximately 40% compared to NSAA.
引用
- van de Velde NM, Hooijmans MT, Sardjoe Mishre ASD, et al. Selection Approach to Identify the Optimal Biomarker Using Quantitative Muscle MRI and Functional Assessments in Becker Muscular Dystrophy. Neurology. 2021. PMID: 34162720. doi:10.1212/WNL.0000000000012233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。